Clinical pharmacology in drug development
Bioequivalence Study of Two Olopatadine Hydrochloride Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions.
Yuyan Lei, Fang Pei, Qingqi Wu, Guiling Xiong, Fengzhi Liu, Xintong Wang, Lulu Chen, Chao Li, Ling Zhou, Qing Fang, Weiming Chen, Dongsheng Ouyang, Xiaohui Li
Published: 202510.1002/cpdd.1629
Abstract
Olopatadine hydrochloride, a second-generation selective histamine H1 receptor antagonist, is an effective anti-allergic agent. This study evaluated the pharmacokinetics and bioequivalence of two olopatadine hydrochloride tablet formulations in healt…
Preview only. Read the full abstract at the source